Examination of blood-derived indices of NASH severity in STZ/HFD mice revealed plasma ALT and IL-6 levels to be similar in vehicle-treated and ALT-100 mAb-treated NAFLD mice (Figure 5A,C). Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.